| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 252,795 | 250,816 | 245,989 | 242,487 | | Cost of Revenue | 44,366 | 46,962 | 48,750 | 53,193 | | | Gross Profit | 208,429 | 203,854 | 197,239 | 189,294 | | | Operating Expenses | | Research Development | 11,627 | 11,945 | 23,872 | 15,233 | | Selling General and Administrative | 59,115 | 53,022 | 46,766 | 44,401 | | Non Recurring |
-
|
-
|
-
| 163,316 | | Others | 56,993 | 56,992 | 56,993 | 59,083 | | | | Total Operating Expenses |
-
|
-
|
-
| 282,033 | | | | Operating Income or Loss | 80,694 | 81,895 | 69,608 | (92,739) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 393,127 | 14 | 65 | 181 | | Earnings Before Interest And Taxes | 473,821 | 81,909 | 69,673 | (92,558) | | Interest Expense | 23,992 | 15,215 | 18,082 | 21,066 | | Income Before Tax | 449,829 | 66,694 | 51,591 | (113,624) | | Income Tax Expense | 25,584 | 10,671 | 8,255 | 2,048 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 424,245 | 56,023 | 43,336 | (115,672) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 424,245 | 56,023 | 43,336 | (115,672) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $424,245 | $56,023 | $43,336 | ($115,672) |
|
0.00% Nasdaq 
0.07%
Income Statement
